Blog
Clinical research results now to be more transparent
Due to a “credibility gap”, drugmakers are now being moved to make reports on clinical research results more transparent, whether the results are good or bad. According to an article on mednews.com by Kevin B. O’Reilly, there have been 10 approved recommendations on...
ACRO presents “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice” at FDA Hearing
During an April 23rd FDA hearing to gather input on ways to modernize the clinical research process, The Association of Clinical Research Organizations (ACRO) provided FDA a number of suggestions to improve the drug development process. ACRO’s main suggestion was to...
Errors Realized for Cancer Study Funding
According to a report by the Institute of Medicine (IOM), the National Cancer Institute’s (NCI) Clinical Trials Cooperative Group program was inefficient, underfunded, and filled with red tape. The NCI program contains 3,100 institutions in the U.S., Canada, and...
Pearl Pathways Attracting National Exposure
PharmaVOICE has featured Pearl Pathways twice in the last year. In January 2012, Pearl President and CEO, Diana Caldwell, shared her thoughts on the expansion of Pearl's services to meet the growing needs of their customers. In April 2012, Chief Operating Officer,...
IHIF Annual Meeting: Monday, May 7
Please join us at the IHIF Annual Meeting from May 7-8. Pearl will be in attendance with 3-4 teammates so be sure to look for us! The topic of the event is: "Statewide Strategic Plan for the Health Sector". To learn more and to register, click here.